The invention discloses a pure Chinese herba preparation for treating 
leukemia, which includes, by weight ratio, from 10 to 30 parts of 
eucommia ulmoides, from 10 to 30 parts of 
morinda officinalis, from 10 to 30 parts of 
cistanche deserticola, from 10 to 30 parts of walnut kernels, from 5 to 10 parts of fennel, from 5 to 10 parts of 
fructus psoraleae, from 5 to 15 parts of pericarpium zanthoxyli, from 10 to 30 parts of 
astragalus mongholicus, from 10 to 20 parts of caulis spatholobi, from 5 to 15 parts of bighead atractylodes 
rhizome, from 5 to 20 parts of 
ligusticum wallichii, from 5 to 15 parts of 
salvia miltiorrhiza, from 5 to 20 parts of radix 
polygonum multiflorum preparata, from 5 to 20 parts of 
grifola, from 5-15 parts of sculellaria barbata, from 5 to 15 parts of wolfberry fruits, from 5 to 15 parts of 
codonopsis pilosula, from 5 to 15 parts of Chinese angelica, from 5 to 15 parts of 
rehmannia glutinosa, from 5 to 15 parts of rhizoma polygonati, from 5 to 10 parts of 
donkey-hide 
gelatin, from 8 to 15 parts of 
panax notoginseng powder, from 10 to 20 parts of dried longan pulp, from 5 to 20 parts of hawthorn, from 5 to 15 parts of Chinese fanpalm seeds, from 5 to 15 parts of 
rohdea japonica, from 10 to 20 parts of glaucescent 
fissistigma roots, from 30 to 50 parts of 
ganoderma lucidum 
spore powder, from 8 to 12 parts of fresh spirulina, from 8 to 12 parts of fresh alfalfa juice and from 4 to 6 parts of buddha-
fruit juice. The pure Chinese herba preparation treats the 
leukemia by means of reinforcing 
kidney, warming yang and invigorating qi and blood, and is remarkable in 
curative effect and low in cost.